Douglas Doerfler - Jul 29, 2021 Form 3 Insider Report for MAXCYTE, INC. (MXCT)

Role
President and CEO, Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
MXCT
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
3
Date filed
7/29/2021, 06:35 PM
Next filing
Aug 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MXCT Common Stock 433K Jul 29, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MXCT Employee Stock Option (right to buy) Jul 29, 2021 Common Stock 645K $0.04 Direct F1
holding MXCT Employee Stock Option (right to buy) Jul 29, 2021 Common Stock 296K $1.12 Direct F1, F2
holding MXCT Employee Stock Option (right to buy) Jul 29, 2021 Common Stock 296K $3.33 Direct F1, F2
holding MXCT Employee Stock Option (right to buy) Jul 29, 2021 Common Stock 296K $3.34 Direct F2, F3
holding MXCT Employee Stock Option (right to buy) Jul 29, 2021 Common Stock 390K $2.44 Direct F2, F4
holding MXCT Employee Stock Option (right to buy) Jul 29, 2021 Common Stock 390K $1.87 Direct F2, F5
holding MXCT Employee Stock Option (right to buy) Jul 29, 2021 Common Stock 390K $14.30 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable.
F2 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of GBP 1.00 to $1.3749 as of July 23, 2021.
F3 The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on August 18, 2018, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F4 The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F5 The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F6 Twenty-five percent (25%) of the shares underlying this option shall vest on January 13, 2022, and the remainder vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney